Company / R&D per Share
TREACE MEDICAL CONCEPTS, INC. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.25
FY2025
5-year range
$0.11 / $0.25
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has increased for 3 consecutive years, from $0.11 in FY2022 to $0.25 in FY2025.
Based on SEC 10-K filings.
0.25 in FY2025 with a 3-year CAGR of +33.0%.
Improved from $0.18 to $0.25 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +33.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 3.2% year-over-year.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | +3.2% |
| FY2024 | $0.25 | +34.0% |
| FY2023 | $0.18 | +70.0% |
| FY2022 | $0.11 | -21.4% |
| FY2021 | $0.14 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026